+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Multiplex real-time RT-PCR for prospective evaluation of WT1 and fusion gene transcripts in newly diagnosed de novo acute myeloid leukemia

Multiplex real-time RT-PCR for prospective evaluation of WT1 and fusion gene transcripts in newly diagnosed de novo acute myeloid leukemia

Leukemia and Lymphoma 45(9): 1803-1808

Prognostic assessment is crucial for the management of AML. Although the use of karyotype analysis for risk-stratification is widely accepted, prognosis of AML remains ambiguous, particularly for patients categorized into the intermediate cytogenetic risk group and additional markers are required for an accurate prediction of outcome. For this study, we used multiplex real-time RT-PCR, which can simultaneously quantify WT1 and 10 distinct fusion gene transcripts, to prospectively evaluate the pre-treatment bone marrow findings of 53 de novo AML patients. Five patients with normal karyotype or insufficient metaphases detected by conventional karyotype analysis proved to have AML1-MTG8, CBFbeta-MYH11 or PML-RARalpha fusion transcripts. WT1 overexpression was observed in 92% of the patients, and the levels were significantly higher in the cytogenetic favorable risk group, especially patients with PML-RARalpha. WT1 levels also correlated with the percentage of blasts in bone marrow, especially in cases of core-binding factor leukemia. There was no association between initial WT1 levels and outcome in terms of event-free survival or overall survival. These results suggest that multiplex real-time RT-PCR is rapid and useful for the precise cytogenetic stratification of AML, and that WT1 levels at presentation correlate with several biologic features of leukemia, but have no prognostic significance.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 049640489

Download citation: RISBibTeXText

PMID: 15223639

DOI: 10.1080/10428190410001693551

Related references

The Use of Housekeeping Genes for Real Time RT-PCR Based Quantification of Fusion Gene Transcripts in Acute Myeloid Leukemia. Blood 100(11): Abstract No 4452, 2002

Quantitative kinetics of PML/RARa transcripts using real-time RT-PCR according to the use of cytarabine for consolidation in patients with newly diagnosed acute promyelocytic leukemia A prospective randomized trial. Blood. 98(11 Part 2): , Ember 16, 2001

Multiplex real-time quantitative RT-PCR for standardized monitoration of the t BCR-ABL fusion-transcripts in chronic myeloid leukemia patients. Blood 94(10 Suppl. 1 Part 2): 211b, 1999

Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15(1): 1-5, 2007

A real-time quantitative RT-PCR assay for monitoring DEK-CAN fusion transcripts arising from translocation t(6;9) in acute myeloid leukemia. Leukemia Research 28(11): 1213-1215, 2004

Quantitative analysis of AML1-ETO fusion transcripts in t -positive acute myeloid leukemia during induction chemotherapy using real time RT-PCR. Blood 96(11 Part 2): 200b, 2000

Multiplex RT-PCR Assay for Detection of Common Fusion Transcripts in Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia Cases. Asian Pacific Journal of Cancer Prevention 17(2): 677-684, 2016

Multiplex RT-PCR for the detection of common BCR-ABL fusion transcripts in paraffin-embedded tissues from patients with chronic myeloid leukemia and acute lymphoblastic leukemia. Diagnostic Molecular Pathology 12(3): 119-123, 2003

Evaluation of prospective detection of PML-RARA and RARA-PML fusion transcripts by real-time quantitative PCR (RQ-PCR) to direct pre-emptive therapy with arsenic trioxide (ATO) in acute promyelocytic leukemia (APL) patients treated in the UK MRC AML15 trial.. 2007

Quantification of PML/RAR alpha fusion gene transcripts in patients with acute promyelocytic leukemia by using real-time quantitative PCR. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 25(3): 319-321, 2008

RT-PCR and real-time PCR analysis of E2A-PBX1, TEL-AML1, mBCR-ABL and MLL-AF4 fusion gene transcripts in de novo B-lineage acute lymphoblastic leukaemia patients in south India. Journal of Genetics 90(2): 349-353, 2011

Treatment of the newly diagnosed adult with de novo acute myeloid leukemia. Hematology/Oncology Clinics of North America 7(1): 47-64, 1993

Detection of aml-1/eto fusion gene in patients with acute myeloid leukemia by real-time quantitative RT-PCR. Zhongguo Shi Yan Xue Ye Xue Za Zhi 17(1): 17-22, 2009

Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response. Blood 120(23): 4649-4652, 2012

Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients. Leukemia 16(12): 2447-2453, 2002